PR
COGT icon

PSP Research’s Cogent Biosciences COGT Stock Holding History

PSP Research’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Hold
12,000
– – 0.25% 25
2026
Q1 		$462K Sell
12,000
-1,233
-9% -$45.5K 0.33% 32
2025
Q4 		$470K Buy
+13,233
New +$372K 0.41% 80

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PSP Research's COGT Position: Q2 2026 in Review

PSP Research held its Cogent Biosciences (COGT) position steady in Q2 2026 at 12,000 shares worth $464K. The position accounts for 0.25% of the portfolio, ranked #25.

PSP Research first reported a position in COGT in Q4 2025 and has held it in 3 quarters since. The position peaked at $470K in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • PSP Research held 12,000 shares of Cogent Biosciences worth $464K as of Q2 2026.
  • PSP Research left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up 0.25% of PSP Research's portfolio in Q2 2026, its #25 holding.
  • PSP Research first reported a position in Cogent Biosciences in Q4 2025 and has held it in 3 quarters since.
  • PSP Research's Cogent Biosciences position peaked at $470K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on PSP Research's 13F filing for Q2 2026, filed 9 Jul 2026.